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Objective: The objective of this clinical case 
presentation is to help dental hygienist 
recognize and understand the treatment of 
gingival hyperplasia. Assessment: A 56 year 
old Caucasian male presented to the dental 
hygiene clinic with the chief complaint, “I 
want my teeth cleaned”. The patient’s last 
cleaning was in 2011 at Indiana University 
School of Dentistry (IUSD). The patient’s 
medical history revealed that he smokes one 
pack a day and has been taking the calcium 
channel blocker amlodipine for approximately 
two months for hypertension.  Amlodipine is 
known to cause gingival hyperplasia. [1] The 
patient’s gum tissue presented clinically as 
pink, stippled, rolled, and bulbous with a 
hyperplastic appearance.  The mandibular 
attached gingiva in particular, was firm and 
had an enlarged clinical appearance. DH Care 
Plan: Treatment for this patient at the IUSD 
hygiene clinic includes scaling and root 
planing on the maxilla, with full mouth 
debridement, and a tissue re-evaluation 4-6 
weeks after treatment. Evaluation: Due to time 
constraints associated with this presentation, 
this patient has yet to be re-evaluated after 
treatment at IUSD. Conclusion: Gingival 
hyperplasia can manifest from mild to severe 
depending on modifying factors including the 
patient’s ability to remove plaque biofilm and 
the length of time the patient is on 
amlodipine. [3] Each case of gingival 
hyperplasia should be treated based on the 
individual’s needs; this can include non-
surgical therapy, surgical procedures, or a 
combination of both. Drug-induced gingival 
hyperplasia was reclassified in 1999 by APP 
as a dental plaque-induced gingival disease. 
Hygienist must stress the importance of 
plaque control and spend quality time on oral 
hygiene instructions. If a patient is on a known 
medication with this effect it is important to 
note any gingival changes at each visit.  
Amlodipine is a commonly prescribed drug 
with the prevalence of gingival hyperplasia 
being reported as high as 33.3%. [5]  
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INTRODUCTION CONCLUSION 
Gingival Hyperplasia is sometimes 
called gingival overgrowth when 
associated with medication-related 
enlargement. It is an abnormal 
proliferation of extracellular matrix of 
periodontal tissues[4]. Drugs that can 
cause this include, anticonvulsants, 
immunosuppressants, and calcium 
channel blockers.[1] The group of 
calcium channel blockers more 
commonly associated with gingival 
hyperplasia are the dihydropyridines,  
these include nifedipine, felodipine, 
and amlodipine.[2] 
ihydropyridine Molecule 
-Clinical Appearance-  
Granular and pebbly gingiva 
Diffuse thickened gingiva 
Interdental papillae may be abnormally 
enlarged 
The more severe the more diffuse the 
enlargement is typically.  
Commonly seen in the anterior labial 
gingiva, but can be present in posterior. 
  
-Other- 
Medical history shows patient is taking 
drug with known cause of gingival 
enlargement. 
Gingival hyperplasia is not fully 
understood. Studies show it is 
multifactorial in nature. [4] Oral 
Hygiene status of the patient is one 
factor that may affect the severity of 
this side effect. The dental hygienist 
must be able to recognize, treat, and 
provide maintenance for patients with 
gingival hyperplasia. Dental hygienist 
should modify treatment based on each 
individual's needs .  Reducing the 
amount of plaque biofilm  will decrease 
the chance of an inflammatory response 
leading to periodontal disease. 
